Robert Newton

20.4k total citations · 2 hit papers
268 papers, 13.3k citations indexed

About

Robert Newton is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Robert Newton has authored 268 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Molecular Biology, 80 papers in Oncology and 78 papers in Immunology. Recurrent topics in Robert Newton's work include Immune Response and Inflammation (52 papers), Asthma and respiratory diseases (49 papers) and Cytokine Signaling Pathways and Interactions (48 papers). Robert Newton is often cited by papers focused on Immune Response and Inflammation (52 papers), Asthma and respiratory diseases (49 papers) and Cytokine Signaling Pathways and Interactions (48 papers). Robert Newton collaborates with scholars based in United States, Canada and United Kingdom. Robert Newton's co-authors include Peter J. Barnes, Neil S. Holden, Mark A. Giembycz, Peggy Scherle, Ian M. Adcock, Carl P. Decicco, Maryanne Covington, L.M. Kuitert, Martin Bergmann and Richard Leigh and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Robert Newton

264 papers receiving 13.0k citations

Hit Papers

Mechanism of tumor rejection with doublets of CTLA-4, PD-... 2014 2026 2018 2022 2014 2020 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment
    2014 456 citations Holly K. Koblish, Peggy Scherle et al. profile →
  2. Clinicogenomic Analysis of FGFR2 -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib
    2020 191 citations Ian M. Silverman, Antoine Hollebecque et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Newton United States 67 4.6k 3.6k 3.0k 2.5k 2.0k 268 13.3k
Babette B. Weksler United States 72 4.4k 1.0× 1.9k 0.5× 1.8k 0.6× 2.0k 0.8× 1.3k 0.6× 214 15.5k
John Westwick United Kingdom 64 6.0k 1.3× 3.9k 1.1× 3.0k 1.0× 1.7k 0.7× 1.3k 0.7× 239 13.8k
Josef Pfeilschifter Germany 79 11.8k 2.6× 4.8k 1.3× 2.0k 0.6× 4.6k 1.8× 2.3k 1.2× 544 24.4k
Eric Jaffe United States 38 5.5k 1.2× 2.5k 0.7× 947 0.3× 2.5k 1.0× 2.3k 1.1× 89 15.6k
Roderick J. Flower United Kingdom 58 6.1k 1.3× 4.3k 1.2× 996 0.3× 2.0k 0.8× 1.0k 0.5× 135 13.8k
Athanasios G. Papavassiliou Greece 68 8.0k 1.7× 1.6k 0.4× 3.2k 1.0× 1.4k 0.6× 2.7k 1.3× 488 17.5k
Jan Tavernier Belgium 72 6.3k 1.4× 6.5k 1.8× 2.8k 0.9× 3.5k 1.4× 1.2k 0.6× 314 17.3k
Marc Peters‐Golden United States 72 4.9k 1.1× 4.7k 1.3× 1.4k 0.5× 4.6k 1.9× 1.2k 0.6× 274 17.3k
Carlo Riccardi Italy 61 6.3k 1.4× 7.9k 2.2× 3.1k 1.0× 1.2k 0.5× 1.7k 0.8× 316 17.8k
Toby Lawrence United Kingdom 44 6.0k 1.3× 7.3k 2.0× 2.4k 0.8× 1.0k 0.4× 2.9k 1.4× 79 16.0k

Countries citing papers authored by Robert Newton

Since Specialization
Citations

This map shows the geographic impact of Robert Newton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Newton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Newton more than expected).

Fields of papers citing papers by Robert Newton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Newton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Newton. The network helps show where Robert Newton may publish in the future.

Co-authorship network of co-authors of Robert Newton

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Newton. A scholar is included among the top collaborators of Robert Newton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Newton. Robert Newton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Mostafa, Mahmoud, Aubrey N. Michi, Sarah K. Sasse, et al.. (2020). Genomic determinants implicated in the glucocorticoid-mediated induction of KLF9 in pulmonary epithelial cells. Journal of Biological Chemistry. 296. 100065–100065. 12 indexed citations
5.
Silverman, Ian M., Antoine Hollebecque, Luc Friboulet, et al.. (2020). Clinicogenomic Analysis of FGFR2 -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib. Cancer Discovery. 11(2). 326–339. 191 indexed citations breakdown →
6.
Newton, Robert, et al.. (2016). The Hardness of the Wheat Kernel in Relation to Protein Content.. Scientific Agriculture.
7.
Shah, Suharsh, Elizabeth King, & Robert Newton. (2013). Inhibition of inflammatory gene expression by dexamethasone partly depends on the phosphatase, MKP-1 (DUSP1). European Respiratory Journal. 42(Suppl 57). P730–P730. 1 indexed citations
8.
Holden, Neil S., Christopher F. Rider, Elizabeth M. King, et al.. (2011). β 2 -Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids. Proceedings of the National Academy of Sciences. 108(49). 19713–19718. 69 indexed citations
9.
Liu, Xiangdong, Qian Wang, Gengjie Yang, et al.. (2011). A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3. Clinical Cancer Research. 17(22). 7127–7138. 190 indexed citations
10.
Shin, Niu, Maryanne Covington, Di Bian, et al.. (2011). INCB38579 is a novel, potent and selective histamine H4 receptor antagonist with activity in rodent models of inflammatory pain (117.28). The Journal of Immunology. 186(1_Supplement). 117.28–117.28. 1 indexed citations
11.
Hegyi, László, Khin Thway, Robert Newton, et al.. (2009). Malignant myoepithelioma arising in adenomyoepithelioma of the breast and coincident multiple gastrointestinal stromal tumours in a patient with neurofibromatosis type 1. Journal of Clinical Pathology. 62(7). 653–655. 10 indexed citations
12.
Liu, Xiangdong, Jordan S. Fridman, Qian Wang, et al.. (2006). Selective inhibition of ADAM metalloproteases blocks HER-2 extracellular domain (ECD) cleavage and potentiates the anti-tumor effects of trastuzumab. Cancer Biology & Therapy. 5(6). 648–656. 45 indexed citations
13.
Giembycz, M A & Robert Newton. (2006). Beyond the dogma: novel β2-adrenoceptor signalling in the airways. European Respiratory Journal. 27(6). 1286–1306. 104 indexed citations
14.
Birrell, Mark A., Elizabeth Hardaker, Sissie Wong, et al.. (2005). Iκ-B Kinase-2 Inhibitor Blocks Inflammation in Human Airway Smooth Muscle and a Rat Model of Asthma. American Journal of Respiratory and Critical Care Medicine. 172(8). 962–971. 107 indexed citations
15.
Xue, Chu‐Biao, John Roderick, James J.‐W. Duan, et al.. (2003). Rational design, synthesis and structure–Activity relationships of a cyclic succinate series of TNF-α converting enzyme inhibitors. Part 1: lead identification. Bioorganic & Medicinal Chemistry Letters. 13(24). 4293–4297. 21 indexed citations
16.
Staples, Karl J., Martin Bergmann, Katsuyuki Tomita, et al.. (2001). Adenosine 3′,5′-Cyclic Monophosphate (cAMP)-Dependent Inhibition of IL-5 from Human T Lymphocytes Is Not Mediated by the cAMP-Dependent Protein Kinase A. The Journal of Immunology. 167(4). 2074–2080. 63 indexed citations
17.
Beral, Valerie, Robert Newton, & G Reeves. (2000). International collaboration on HIV and cancer. JAIDS Journal of Acquired Immune Deficiency Syndromes. 23. 66 indexed citations
18.
Newton, Robert, Lorraine Hart, David A. Stevens, et al.. (1998). Effect of dexamethasone on interleukin‐1β‐(IL‐1β)‐induced nuclear factor‐κB (NF‐κB) and κB‐dependent transcription in epithelial cells. European Journal of Biochemistry. 254(1). 81–89. 89 indexed citations
19.
Arner, Elizabeth C., et al.. (1987). Effect of antiinflammatory drugs on human interleukin-1-induced cartilage degradation. Inflammation Research. 21(3-4). 334–336. 16 indexed citations
20.
Graham, J. H., C. L. Rhykerd, & Robert Newton. (1960). Internal breakdown in crown of red clover.. ˜The œPlant disease reporter. 44(1). 59–61. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Babette B. Weksler Breakdown of academic impact, for papers by John Westwick Breakdown of academic impact, for papers by Josef Pfeilschifter Breakdown of academic impact, for papers by Eric Jaffe Breakdown of academic impact, for papers by Roderick J. Flower Breakdown of academic impact, for papers by Athanasios G. Papavassiliou Breakdown of academic impact, for papers by Jan Tavernier Breakdown of academic impact, for papers by Marc Peters‐Golden Breakdown of academic impact, for papers by Carlo Riccardi Breakdown of academic impact, for papers by Toby Lawrence
Rankless by CCL
2026